PEAK6
PGEN icon

PEAK6’s Precigen PGEN Stock Holding History

PEAK6’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$171K Buy
+30,000
New +$130K ﹤0.01% 2306

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PEAK6's PGEN Position: Q2 2026 in Review

PEAK6 opened a new position in Precigen (PGEN) in Q2 2026: 30,000 shares worth $171K. The stake represents ﹤0.01% of the portfolio and ranks #2306 among its holdings.

211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • PEAK6 held 30,000 shares of Precigen worth $171K as of Q2 2026.
  • Precigen was a new PEAK6 position in Q2 2026.
  • Precigen made up ﹤0.01% of PEAK6's portfolio in Q2 2026, its #2306 holding.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on PEAK6's 13F filing for Q2 2026, filed 13 Aug 2026.